drugset / Trial / NCT01648764
A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate two different dosing regimens of LY2334737 in participants with cancer that is advanced and/or has spread to other parts of the body. Information about side effects will be collected.
Timeline
- Start
- 2008-09
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2334737 | Small molecule | 40 mg | Oral |
| Subject | LY2334737 | Small molecule | 200 mg | Oral |